ESG

With dentist burnout at crisis levels, one veteran practitioner offers a $6M blueprint to help owners escape the grind and reclaim their lives.

A new giant enters the ring. Akralos Animal Nutrition, an ADM-Alltech venture, launches with 40+ mills, aiming to reshape the North American market.

The French data science leader's first acquisition signals a major play in the AI consolidation game, aiming to fuse strategic ROI with granular customer analytics.

A new report projects massive growth in the plant-based sector, driven by tech innovation, corporate investment, and a worldwide shift in consumer habits.

Death rates fall, but a new report reveals rising incidence and stark inequities. Can new drugs and AI reshape the future for all patients?

Amid rising drug price scrutiny, Red Nucleus acquires an AI-powered consultancy to revolutionize how biopharma proves the value of new medicines.

Beyond M&A, ACROBiosystems' bioSeedin summit redefines growth, connecting global capital with biotech innovation in a new era of strategic partnerships.

As AI systems deny healthcare claims at alarming rates, experts argue that human oversight is the only safeguard for both patients and payors.

MAPS and Columbia University launch a landmark study into MDMA-assisted couples therapy, seeking to turn decades of underground practice into a safe future.

North Carolina residents are invited to shape policy by sharing their daily life experiences in a statewide survey open through February.

A 40-year-old Oregon shoemaker ditches the traditional sale, choosing a unique trust model to secure its legacy, empower workers, and keep jobs local.

A new campaign from ZOLL LifeVest and the AHA targets the deadly disparity in women's cardiac care, blending advocacy with life-saving wearable technology.

From automated bookings to data-driven operations, a new tech tide is rising, promising greater efficiency for operators and better experiences for boaters.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

At MD&M West 2026, Boyd showcases how materials science and regulatory expertise are the unsung heroes behind the next wave of medical wearables.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

Automotive giant Garrett Motion enters the HVAC market with oil-free tech, promising major energy savings and a greener future for commercial buildings.

Following a federal probe into a Waymo robotaxi hitting a child, the Teamsters union calls for an indefinite ban, escalating the battle over AV safety and jobs.

The AlUla Contemporary Art Museum launches, blending ancient heritage with modern art and global partnerships to redefine Saudi Arabia's cultural landscape.

The analytics giant pays down debt and buys back stock, signaling financial health, but faces analyst skepticism over its long-term growth strategy.